Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease

Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease

Current therapies for autoimmune diseases rely on traditional immunosuppressive medications that expose patients to an increased risk of opportunistic infections and other complications. Immunoregulatory interventions that act prophylactically or therapeutically to induce antigen-specific tolerance...

ver descrição completa

Detalhes bibliográficos
Principais autores: Bilate, Angelina M., Huang, Nai-Jia, Li, Hojun, Patterson, Heide C., Dougan, Stephanie K., Maruyama, Takeshi, Pishesha, Novalia, Wibowo, Marsha C, Dhesycka, Rhogerry, Bousbaine, Djenet, Lodish, Harvey F, Ploegh, Hidde, Li, Zeyang,S.M.Massachusetts Institute of Technology.
Outros Autores: Massachusetts Institute of Technology. Department of Biological Engineering
Formato: Artigo
Publicado em: National Academy of Sciences (U.S.) 2018
Acesso em linha:http://hdl.handle.net/1721.1/113222
https://orcid.org/0000-0001-9306-8271
https://orcid.org/0000-0003-2683-9544
https://orcid.org/0000-0002-7029-7415
https://orcid.org/0000-0002-1090-6071

Internet

http://hdl.handle.net/1721.1/113222
https://orcid.org/0000-0001-9306-8271
https://orcid.org/0000-0003-2683-9544
https://orcid.org/0000-0002-7029-7415
https://orcid.org/0000-0002-1090-6071

Registros relacionados